These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9456942)

  • 1. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
    Diamandidou E; Ajani JA; Yang DJ; Chuang VP; Brown CA; Carrasco HC; Lawrence DD; Wallace S
    AJR Am J Roentgenol; 1998 Feb; 170(2):339-44. PubMed ID: 9456942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
    Winkelbauer FW; Niederle B; Pietschmann F; Thurnher S; Wildling R; Prokesch R; Lammer J
    AJR Am J Roentgenol; 1995 Aug; 165(2):323-7. PubMed ID: 7542430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
    Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
    J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
    Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
    Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
    Strosberg JR; Choi J; Cantor AB; Kvols LK
    Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
    Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
    Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
    AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors.
    Drougas JG; Anthony LB; Blair TK; Lopez RR; Wright JK; Chapman WC; Webb L; Mazer M; Meranze S; Pinson CW
    Am J Surg; 1998 May; 175(5):408-12. PubMed ID: 9600289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic artery embolization for metastatic endocrine-secreting tumors of the pancreas. Report of two cases.
    Clouse ME; Lee RG; Duszlak EJ; Lokich JJ; Alday MT
    Gastroenterology; 1983 Nov; 85(5):1183-6. PubMed ID: 6194040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.
    Christante D; Pommier S; Givi B; Pommier R
    Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
    Clouse ME; Perry L; Stuart K; Stokes KR
    Digestion; 1994; 55 Suppl 3():92-7. PubMed ID: 7698544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies.
    Lopez RR; Pan SH; Lois JF; McMonigle ME; Hoffman AL; Sher LS; Lugo D; Makowka L
    Am Surg; 1997 Oct; 63(10):923-6. PubMed ID: 9322674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
    Kim YH; Ajani JA; Carrasco CH; Dumas P; Richli W; Lawrence D; Chuang V; Wallace S
    Cancer Invest; 1999; 17(7):474-8. PubMed ID: 10518191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms.
    Brown KT; Koh BY; Brody LA; Getrajdman GI; Susman J; Fong Y; Blumgart LH
    J Vasc Interv Radiol; 1999 Apr; 10(4):397-403. PubMed ID: 10229465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.
    Ruszniewski P; Rougier P; Roche A; Legmann P; Sibert A; Hochlaf S; Ychou M; Mignon M
    Cancer; 1993 Apr; 71(8):2624-30. PubMed ID: 8384072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter chemoembolization of progressive carcinoid liver metastasis.
    Therasse E; Breittmayer F; Roche A; De Baere T; Indushekar S; Ducreux M; Lasser P; Elias D; Rougier P
    Radiology; 1993 Nov; 189(2):541-7. PubMed ID: 7692465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.
    Yao KA; Talamonti MS; Nemcek A; Angelos P; Chrisman H; Skarda J; Benson AB; Rao S; Joehl RJ
    Surgery; 2001 Oct; 130(4):677-82; discussion 682-5. PubMed ID: 11602899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embolization and chemoembolization therapy for neuroendocrine tumors.
    Venook AP
    Curr Opin Oncol; 1999 Jan; 11(1):38-41. PubMed ID: 9914876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.